These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort. Rhee EJ, Park SE, Oh HG, Park CY, Oh KW, Park SW, Blankstein R, Plutzky J, Lee WY. Atherosclerosis; 2015 May 13; 240(1):242-9. PubMed ID: 25818250 [Abstract] [Full Text] [Related]
7. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study. Pavlovic J, Greenland P, Deckers JW, Brugts JJ, Kavousi M, Dhana K, Ikram MA, Hofman A, Stricker BH, Franco OH, Leening MJ. JAMA Cardiol; 2016 Sep 01; 1(6):708-13. PubMed ID: 27439175 [Abstract] [Full Text] [Related]
8. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat. Mortensen MB, Nordestgaard BG. JAMA Cardiol; 2019 Nov 01; 4(11):1131-1138. PubMed ID: 31577339 [Abstract] [Full Text] [Related]
10. Assessment of Coronary Artery Calcium Scoring for Statin Treatment Strategy according to ACC/AHA Guidelines in Asymptomatic Korean Adults. Han D, Ó Hartaigh B, Lee JH, Rizvi A, Park HE, Choi SY, Sung J, Chang HJ. Yonsei Med J; 2017 Jan 01; 58(1):82-89. PubMed ID: 27873499 [Abstract] [Full Text] [Related]
11. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers. Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, Leo MC, Puro J, Persell SD. J Am Heart Assoc; 2017 Jul 03; 6(7):. PubMed ID: 28673901 [Abstract] [Full Text] [Related]
12. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study. Shah RV, Spahillari A, Mwasongwe S, Carr JJ, Terry JG, Mentz RJ, Addison D, Hoffmann U, Reis J, Freedman JE, Lima JAC, Correa A, Murthy VL. JAMA Cardiol; 2017 Jun 01; 2(6):644-652. PubMed ID: 28315622 [Abstract] [Full Text] [Related]
13. Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts. Akintoye E, Afonso L, Bengaluru Jayanna M, Bao W, Briasoulis A, Robinson J. J Am Heart Assoc; 2021 Jun 15; 10(12):e019589. PubMed ID: 34092110 [Abstract] [Full Text] [Related]
14. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study. Hamoui O, Omar MI, Raal FJ, Rashed W, Kane A, Alami M, Abreu P, Mashhoud W, Alsheikh-Ali AA. BMC Cardiovasc Disord; 2019 Mar 15; 19(1):61. PubMed ID: 30876390 [Abstract] [Full Text] [Related]
15. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, Ikram MA, Stricker BH, Hofman A, Franco OH. JAMA; 2014 Apr 09; 311(14):1416-23. PubMed ID: 24681960 [Abstract] [Full Text] [Related]
18. How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic. Barkas F, Milionis H, Kostapanos MS, Mikhailidis DP, Elisaf M, Liberopoulos E. Curr Med Res Opin; 2015 Feb 09; 31(2):221-8. PubMed ID: 25418708 [Abstract] [Full Text] [Related]